![]() |
市場調查報告書
商品編碼
2024492
人工智慧驅動的X光成像解決方案市場:按產品、部署模式、工作流程、應用和地區分類(2026-2034年)AI-Enabled X-Ray Imaging Solutions Market by Product, Mode of Deployment, Workflow, Application, and Region 2026-2034 |
||||||
2025年,全球人工智慧驅動的X光成像解決方案市場規模達2.797億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到10.175億美元,2026年至2034年的複合年成長率(CAGR)為14.96% 。醫療產業的穩步擴張、技術的顯著進步以及廣泛的研發活動是推動該市場成長的主要因素。
人工智慧 (AI) 驅動的放射成像解決方案是一套醫療診斷技術,使放射科醫生能夠更快、更準確地評估和檢查各種器官及其狀況的複雜影像。這些解決方案採用各種軟硬體,利用電腦演算法分析數據,並進行預測分析和風險評估。此外,AI 驅動的放射影像解決方案還提供集中式影像擷取、分流、治療決策支援、影像分析、報告和溝通以及診斷等標準服務。這些功能減少了對專科醫生的依賴,實現了資訊主導的診療方法,提高了影像質量,降低了輻射暴露,並使醫療專業人員能夠做出更明智的臨床決策。因此,AI 驅動的放射影像解決方案被廣泛應用於普通放射科和專科放射科,以更深入地了解患者的異常情況並提供更好的治療方案。
人工智慧 (AI) 和其他計算演算法在醫療產業的廣泛應用是市場成長的主要驅動力之一。這導致對用於檢測個體各種慢性病和心血管疾病 (CVD) 的先進影像解決方案的需求增加,這也是另一個成長要素。此外,包括電腦斷層掃描 (CT)、超音波造影 (MR)、乳房X光攝影攝影、多重模式成像系統和超音波在內的多種成像方式的廣泛應用,進一步刺激了全球產品需求,並促進了市場成長。同時,行動X光應用的出現以及軟體功能和設備改進的顯著技術進步也支撐著市場成長。這主要得益於深度學習、機器學習 (ML) 和機器人技術的大規模整合,透過最佳化精度和高級自動化提高了生產力。最後,在新冠疫情期間,人工智慧驅動的X光設備透過遠端醫療實現成像和遠端訪問,其使用量的增加也推動了市場成長。此外,人們對該產品的可靠性、穩定性、易於重現的疾病資訊等多種優勢的認知不斷提高,以及為實現先進自動化而開展的最新研發活動,以及醫療產業的顯著擴張,都對市場成長產生了積極影響。
The global AI-enabled X-ray imaging solutions market size reached USD 279.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,017.5 Million by 2034, exhibiting a growth rate (CAGR) of 14.96% during 2026-2034. The steady expansion in the healthcare industry, significant technological advancements, and extensive research and development (R&D) activities represent some of the key factors driving the market.
Artificial intelligence (AI)-enabled X-ray imaging solutions represent a suit of medical diagnostics that enables radiologists to evaluate and examine intricate images of diverse organs and their conditions at improved speed and accuracy. They employ various software and hardware solutions that use computerized algorithms to analyze data and perform predictive analysis and risk assessments. Moreover, AI-enabled X-ray imaging solutions offer intensive image acquisition, triage, treatment decision support, image analysis, reporting and communication, and diagnosis as standard services. These facilities reduce the requirement of human specialties, allow an information-driven approach, enhance the picture quality, reduce radiation exposure, and enable practitioners to make better clinical decisions. As a result, AI-enabled X-ray imaging solutions are widely used in general and specialty radiology for the extensive clarification of abnormalities amongst patients and provide better treatment solutions.
The widespread integration of artificial intelligence (AI) and other computational algorithms in the healthcare industry represent one of the key factors driving the market growth. In line with this, the increasing need for advanced imaging and diagnostic solutions to detect various chronic and cardiovascular disorders (CVDs) amongst individuals is acting as another growth-inducing factor. Additionally, the extensive utilization of multiple imaging modalities, including computer tomography (CT), magnetic resonance (MR), mammography, multimodality imaging systems, and ultrasound, has further facilitated product demand across the globe, which is contributing to the market growth. Moreover, the advent of mobile X-ray applications and significant technological advancements in terms of improvements in software capabilities and facilities are supporting the market growth. This can be further attributed to the large-scale integration of deep learning, machine learning (ML) and robotics, which help increase productivity by optimizing precision and high-grade automation. Furthermore, the escalating usage of AI-enabled X-rays during the COVID-19 pandemic to diagnose and gain remote access to images via telehealth is favoring the market growth. Apart from this, the rising awareness regarding multiple product benefits, such as reliability, stability and instant reproducible disease information and recent research and development (R&D) activities to enable high-grade automation, along with significant expansion in the healthcare industry are positively impacting the market growth.
The publisher provides an analysis of the key trends in each segment of the global AI-enabled X-ray imaging solutions market, along with forecasts at the global, regional, and country level from 2026-2034. Our report has categorized the market based on product, mode of deployment, workflow, and application.
The report has also provided a detailed breakup and analysis of the AI-enabled X-ray imaging solutions market based on the product. This includes software (perpetual, subscription, and fee-per-case software license) and hardware. According to the report, software represented the largest segment.
The report has also provided a detailed breakup and analysis of the AI-enabled X-ray imaging solutions market based on the workflow. This includes detection, image acquisition, image analysis, diagnosis and treatment decision support, triage, predictive analysis and risk assessment, and reporting and communication. According to the report, detection represented the largest segment.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for AI-enabled X-ray imaging solutions. Some of the factors driving the North America AI-enabled X-Ray imaging solutions market included the widespread adoption of artificial intelligence (AI) applications, the increasing need for advanced imaging and diagnosing technologies to detect chronic ailments, and extensive research and development (R&D) activities.
The report has also provided a comprehensive analysis of the competitive landscape in the global AI-enabled X-ray imaging solutions market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Arterys Inc., Behold.ai Technologies Limited, Imagen Technologies Inc., Infervision Medical Technology Co. Ltd., Lunit Inc., Qure.ai Technologies Private Limited, VUNO Inc., etc.